Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group
Maria Dêbiec‐Rychter(KU Leuven), Herlinde Dumez(KU Leuven), Ian Judson(Royal Marsden Hospital), Bartosz Wasąg(KU Leuven), Jaap Verweij(Erasmus MC), Matthew F. Brown(European Organisation for Research and Treatment of Cancer), Saša Dimitrijević(Novartis (Switzerland)), Raf Sciot(KU Leuven), Michel Stul(KU Leuven), H. Vranck(KU Leuven), Michelle Scurr(Royal Marsden Hospital), A Hagemeijer(KU Leuven), M. van Glabbeke(European Organisation for Research and Treatment of Cancer), A.T. van Oosterom(KU Leuven)
Cited by 442
Abstract
Related Papers
No related papers found
Powered by citation graph analysis